Search results
AstraZeneca selects new heart failure target with BenevolentAI
Pharmaceutical Technology via Yahoo Finance· 3 hours agoIn January 2022, the deal was expanded to include heart failure and systemic lupus erythematosus,...
RemeGen Celebrates World Lupus Day 2024 with Increased Lupus Visibility through Vital Knowledge...
KAMR Amarillo· 6 days agoThe biotech company continues to offer hope to systemic lupus erythematosus (SLE) patients globally...
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So. | The Motley Fool
The Motley Fool· 23 hours agoLacking a big milestone payment like the one in Q1 2023, CRISPR's revenue plummeted 99.5% year over...
Toni Braxton Feels 'Anxiety' About Her Lupus Flaring Up at Vegas Residency: 'Doctor Said I'm Ready'...
People Magazine· 6 days agoToni Braxton feels ready to perform, but it's hard to know when her body will have other plans. The...
BenevolentAI and AstraZeneca discover novel heart failure target using AI
Proactive Investors· 1 day agoThe partnership between Benevolent AI and AstraZeneca, which began in 2019 and was expanded in 2022...
Exagen (NASDAQ:XGN) PT Raised to $7.00 at Cantor Fitzgerald
ETF DAILY NEWS· 10 hours agoExagen (NASDAQ:XGN – Get Free Report) had its price target hoisted by equities research analysts at Cantor Fitzgerald from $5.00 to $7.00 in a report released on Tuesday, Benzinga reports. The ...
Why autoimmune disorder lupus affect women more than men
Investing.com· 6 days agoThe condition, also known as Systemic Lupus Erythematosus (SLE), affects millions of individuals...
WestGene's mRNA Therapeutic Cancer Vaccine Receives FDA Approval
Rome Sentinel· 6 days agoWestGene, a biotech company dedicated to mRNA technology, announces a historic milestone with the...
Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag
Zacks via Yahoo Finance· 2 days agoAllogene (ALLO) reports drab first-quarter 2024 results. The company secures the development and...
Earnings call: Exagen outlines Q1 growth, raises 2024 outlook By Investing.com
Investing.com· 3 days agoLooking ahead, Exagen has raised its full-year revenue guidance to at least $55 million and improved...